Acinetobacter baumannii: assessing susceptibility patterns, management practices, and mortality predictors in a tertiary teaching hospital in Lebanon

Table 5 Comparison of survival time between patients infected with XDR and non-XDR A. baumannii isolates

Group	30-days mortality	Mean survival time (days)	95% CI	Log-rank X² test	P
Group	n (%)	Mean ± SD	95% CI	Log-rank X² test	P
Non-XDR^a (N = 61)	41 (51.8)	10.7 ± 1.1	8.5 ± 12.8	5.45	0.02*
XDR (N = 44)	38 (48.1)	7.2 ± 1.0	5.0 ± 9.2	5.45	0.02*

CI, Confidence interval; SD, standard deviation; XDR, extensively drug resistant
^aIncludes non-multidrug resistant and multidrug resistant A. baumannii isolates
*Statistically significant (P < 0.05)

ISSN: 2047-2994